Contact
Please use this form to send email to PR contact of this press release:
RedHill Biopharma Announces Enrollment of Last Patient in BEKINDA® Phase III Study for Acute Gastroenteritis
TO:
Please use this form to send email to PR contact of this press release:
RedHill Biopharma Announces Enrollment of Last Patient in BEKINDA® Phase III Study for Acute Gastroenteritis
TO: